Evidence map›Paper›PMID 21297472›Full record

ReviewCurrent opinion in obstetrics & gynecology2011

Evolving applications of microarray analysis in prenatal diagnosis.

Melissa S Savage, Mirella J Mourad, Ronald J Wapner

Abstract readReview
In one paragraph

Review in Current opinion in obstetrics & gynecology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. How to choose a test for prenatal genetic diagnosis: a practical overview.American journal of obstetrics and gynecology · 2023
    Article
  3. Review
  4. Review
  5. Article
  6. Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Women's experiences receiving abnormal prenatal chromosomal microarray testing results.Genetics in medicine : official journal of the American College of Medical Genetics · 2013
    Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Melissa S SavageDivision of Reproductive Genetics, Department of Obstetrics and Gynecology, Columbia University, New York, New York, USA.
Mirella J Mourad
Ronald J Wapner
Columbia University · US

Funding

Prenatal Genetic Diagnosis by Genomic Sequencing: A Prospective EvaluationR01HD055651 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Wendy K Chung, Vaidehi Jobanputra · 2007 to 2026
$16.5M
NICHD NIH HHS R01 HD055651
6 · The paper itself

Abstract

purpose of reviewEvaluation of copy number variation by microarray analysis has significant advantages over standard metaphase karyotyping and is quickly becoming the primary means of postnatal genetic evaluation for neonates and infants with dysmorphic features or cognitive difficulties. Before this technology is routinely used for prenatal diagnosis, further evaluation of its value and the clinical dilemmas it may introduce requires further study. This article reviews the recent literature on array technology use in prenatal diagnosis. RECENT

findingsThe use of microarray analysis for routine prenatal diagnosis is still being investigated. Use in certain prenatal situations such as the fetus with structural anomalies or those who are stillborn appears to add important, clinically relevant information. There are a broad range of array designs available and recent research has focused on the appropriate design for prenatal testing. Patient counseling may occasionally be difficult because of the uncertain phenotype associated with some array findings. SUMMARY: We present a brief overview of microarray technology including benefits and limitations. Previous research regarding use of microarray in prenatal diagnosis including specific scenarios of anomalous fetuses and abnormal karyotype is reviewed. Current guidelines and the authors' recommendations are presented.

Indexed as

Chromosome AberrationsCognition DisordersCongenital AbnormalitiesCytogeneticsFemaleGenetic CounselingGenetic MarkersHumansKaryotypingModels, GeneticOligonucleotide Array Sequence AnalysisPhenotypePolymorphism, Single NucleotidePregnancyPrenatal DiagnosisTranslocation, GeneticGenetic Markers

Identifiers

PMID21297472
PMCPMC4384124
OpenAlexW2001803024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.